GGrantIndex
Sort

172,184 grants matching inflammation

Repairing the intestinal epithelium from the dual action of HIV and drug use

$784,575
Alan David Levine · Case Western Reserve University · DP1 · FY2016 · DA

Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza

$784,554
Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2013 · AI

Tumor microenvironments determing migration, dissemination and dormancy

$784,552
John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2012 · CA

Diesel, Allergens and Gene Interaction and Child Atopy

$784,548
Grace Lemasters · University Of Cincinnati · R01 · FY2007 · ES

Minimally Invasive High Intensity Therapeutic Ultrasound for the Treatment of Obstructive Hypertrophic Cardiomyopathy

$784,548
Howard Levin · Coridea, Llc · R44 · FY2023 · HL

The Role of Vascular MR-Regulated Genes in Vascular Function and Disease

$784,522
Iris Z Jaffe · Tufts Medical Center · R01 · FY2021 · HL

The Role of Vascular MR-Regulated Genes in Vascular Function and Disease

$784,522
Iris Z Jaffe · Tufts Medical Center · R01 · FY2022 · HL

Clinical Development of Elafin as a PAH Therapy

$784,522
Roham Zamanian · Stanford University · P01 · FY2017 · HL

The Role of Vascular MR-Regulated Genes in Vascular Function and Disease

$784,522
Iris Z Jaffe · Tufts Medical Center · R01 · FY2023 · HL

Innate Immune Clearance of Host-Adapted Pulmonary Pathogens

$784,510
Alice S Prince · Columbia University Health Sciences · R35 · FY2018 · HL

Regional monitoring of CF lung disease after changes in mechanical airway-clearance treatment

$784,505
Jason C Woods · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL

Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis

$784,482
Jonathan S Lewin · Emory University · P51 · FY2021 · OD

Project 3: Intraarticular Mineralization

$784,477
Tuhina Neogi · Boston University Medical Campus · U19 · FY2024 · AG

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

$784,472
Frank G. Ondrey · University Of Minnesota · R01 · FY2025 · CA

Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study

$784,467
Vaia Lida Chatzi · University Of Southern California · U01 · FY2025 · HG

Early detection of type 1 diabetes via Exosome Technology with Optoelectronics Lab-on-chip: EXTOL

$784,462
Luke P. Lee · Brigham And Women'S Hospital · R01 · FY2022 · DK

Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma

$784,421
Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL

Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma

$784,421
Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL

Ancillary Study: Identification of Plasma Biomarkers in COPD

$784,389
Steven G Kelsen · Temple Univ Of The Commonwealth · RC2 · FY2009 · HL

Molecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic Populations

$784,351
Bing Yu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · HL

Nutrition, terminal NAD metabolites and cardiovascular disease

$784,329
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL

Nutrition, terminal NAD metabolites and cardiovascular disease

$784,329
Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · HL

Radon Asthma Intervention Trial (ROME)

$784,318
Wanda Phipatanakul · Boston Children'S Hospital · R01 · FY2025 · HL

Translational Geroscience Network

$784,286
James L. Kirkland · Mayo Clinic Rochester · R33 · FY2023 · AG

Post-transcriptional modification in esophageal basal cells.

$784,280
Jianwen Que · Columbia University Health Sciences · R01 · FY2025 · DK